Latest Erythropoietin Stories
NEW YORK and BOULDER, Colo., May 20, 2014 /PRNewswire-USNewswire/ -- People are individuals. They differ. Patients differ too.
A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease.
Interest in ZS-9 and Patiromer is High After Review of Respective Product Profiles, According to Findings from Decision Resources Group BURLINGTON, Mass., April 9, 2014 /PRNewswire/ -- Decision
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8zbxmj/investigation) has announced the addition of the
ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Epoetin Alfa Market, 2009-2018” to its store. Dallas, TX (PRWEB) March
The CKD Market Will Decline Through 2017, Due to Genericization of Expensive Agents and Reimbursement Constraints in the U.S., According to Findings from Decision Resources Group BURLINGTON,
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.